COVID-19 Vaccination after Allogeneic Stem Cell Transplantation: Real Word Data on Safety and Efficacy. a Single Center Experience.

por Neagoie, Adela, Sommer, Charlotte, Gantner, Andrea, Wais, Verena, Schnell, Jacqueline, Simon, Hannah, Viardot, Andreas, Döhner, Hartmut, Bunjes, Donald, Sala, Elisa
Publicado 2021

The Effect of COVID-19 Vaccine in Patients with Immune Thrombocytopenia

por Visser, Chantal, Swinkels, Maurice, van Werkhoven, Erik D., Croles, F. Nanne, Noordzij, Heike, Eefting, Matthijs, Last-Koopmans, Suzanne M., Idink, Cecile, Westerweel, Peter E., Santbergen, Bart, Jobse, Pieter A., Baboe, Fazil, Consortium, Recovac-IR, Levin, Mark-David, Kruip, Marieke J.H.A., Jansen, A.J. Gerard
Publicado 2021

Increase in Antibody Titers Following Sars-Cov-2 Vaccination Remains Limited for More Than 3 Years after Final Dose of Anti-CD20 Antibody

por Funakoshi, Yohei, Yakushijin, Kimikazu, Ohji, Goh, Sakai, Hironori, Hojo, Wataru, Watanabe, Marika, Saeki, Miki, Hirakawa, Yuri, Sakai, Rina, Matsumoto, Sakuya, Mizutani, Yu, Kitao, Akihito, Miyata, Yoshiharu, Saito, Yasuyuki, Kawamoto, Shinichiro, Katsuya, Yamamoto, Ito, Mitsuhiro, Nishimura, Meiko, Imamura, Yoshinori, Kiyota, Naomi, Matsuoka, Hiroshi, Mori, Yasuko, Minami, Hironobu
Publicado 2021

Serologic Responses Following Sars-Cov-2 Vaccination and Factors Influencing It in Patients with Hematological Malignant and Non-Malignant Diseases - a Prospective Multicentric Stu...

por Sertić, Zrinka, Lucijanic, Marko, Bašić-Kinda, Sandra, Serventi Seiwerth, Ranka, Periša, Vlatka, Sertić, Dubravka, Coha, Bozena, Pulanic, Drazen, Šegulja, Dragana, Rogić, Dunja, Valkovic, Toni, Aurer, Igor, Durakovic, Nadira
Publicado 2021

COVID Vaccine Antibody Responses in Patients with Hematologic Malignancies in a Myeloid Enriched Cohort: A Better Antibody Response in Patients with Myeloid Malignancies Than B-Cel...

por Goksu, Suleyman Y, Rolwes, John, Premnath, Naveen, Patel, Prapti, Ikpefan, Ruth, Kaur, Gurbakhash, Vusirikala, Madhuri, Bat, Taha, Chen, Weina, Ramakrishnan, Praveen, Kansagra, Ankit, Anderson, Larry D., Awan, Farrukh T., Collins, Robert H., Chung, Stephen, Madanat, Yazan F.
Publicado 2021

Antibody Response to Vaccination with BNT162b2, mRNA-1273, and ChADOx1 in Patients with Myeloid and Lymphoid Neoplasms

por Rotterdam, Jil, Thiaucourt, Margot, Schwaab, Juliana, Reiter, Andreas, Kreil, Sebastian, Steiner, Laurenz, Popp, Henning D., Hofmann, Wolf-Karsten, Bonatz, Karin, Gerhards, Catharina, Neumaier, Michael, Jawhar, Mohamad, Saussele, Susanne
Publicado 2021

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation

por Haggenburg, Sabine, Lissenberg-Witte, Birgit I., Van Binnendijk, Robert S., Den Hartog, Gerco, Michel, Bhoekhan S., Haverkate, Nienke J.E., De Rooij, Dennis M., Broers, Annoek E.C., Mutsaers, Pim G.N.J., Van Meerten, Tom, van Doesum, Jaap, Kater, Arnon P., Zweegman, Sonja, Van Gils, Marit J., Goorhuis, Bram, Rutten, Caroline E., Hazenberg, Mette D., Nijhof, Inger S.
Publicado 2021

Circulating Levels of Ang/Tie2 and VEGF-a Pathway Mediators Are Associated with Clinical Severity, Endothelial Barrier Disruption and Coagulation Activation in COVID-19

por de Moraes, Carla Roberta Peachazepi, de Borba Junior, Ivanio Teixeira, de Lima, Franciele, Barbosa, Mayck Silva, Huber, Stephany Cares, Palma, Andre C., Nunes, Thyago A., Ulaf, Raisa G., Ribeiro, Luciana C., Bernandes, Ana Flavia, Bombassaro, Bruna, Dertkigil, Sergio S., Moretti, Maria Luiza, Bizzacchi, Joyce Annichino, Mansour, Eli, Velloso, Lício Augusto, Maranhão Costa, Fábio Trindade, Orsi, Fernanda Andrade, De Paula, Erich V
Publicado 2021

Sars-Cov-2 Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria: An Italian Multicenter Survey

por Giannotta, Juri Alessandro, Fattizzo, Bruno, Girmenia, Corrado, Ielo, Claudia, Metafuni, Elisabetta, Visentin, Adele, Bianchi, Paola, Apolito, Vincenzo, Beggiato, Eloise, Di Bona, Eros, Sica, Simona, Iori, Anna Paola, Barcellini, Wilma
Publicado 2021

The Deglycosylated Form of 1E12, a Monoclonal Anti-PF4 IgG, Strongly Inhibits Antibody-Triggered Cellular Activation in Vaccine-Induced Thrombotic Thrombocytopenia, and Is a Potent...

por Vayne, Caroline, Palankar, Raghavendra, Billy, Sandra, Handtke, Stefan, Thiele, Thomas, Pouplard, Claire, Greinacher, Andreas, Gruel, Yves, Rollin, Jérôme
Publicado 2021

COVID-19 Infection of HSCT Recipients Is Associated with High Mortality but No Detectable Cytokine Storm at Presentation

por Lucchini, Giovanna, Cozma, Elena, Jackson, Aimee, Gilmour, Kimberly, Protheroe, Rachel Elizabeth, Tholouli, Eleni, Wynn, Robert F, Wilson, Keith, Peggs, Karl S, Potter, Victoria, Parker, Anne, Craddock, Charles, Paneesha, Shankara, Nicholson, Emma, Marks, David I., Mirci-Danicar, Oana, Parrish, Christopher, Martin, Alexander M, McIlroy, Graham, Bishop, Rebecca, Collings, Rebecca, Williams, Ellie, Amrolia, Persis J
Publicado 2021

A Clue to Better Select Chronic Lymphocytic Leukemia Patients with Optimal Response to BNT162b2 mRNA COVID-19 Vaccine

por Molica, Stefano, Giannarelli, Diana, Lentini, Mirella, Zappala, Daniela, Loiacono, Daniela, Gianfelici, Valentina, Panduri, Giuseppina, Minchella, Pasquale, Talarico, Francesco, Levato, Luciano
Publicado 2021

Sars-Cov-2 Antibody Decay Monitoring in mRNA Vaccinated Multiple Myeloma Patients

por Stampfer, Samuel D., Goldwater, Marissa-Skye, Regidor, Bernard Sean S., Jew, Scott Kristian, Bujarski, Sean Elliott, Chen, Haiming, Yashar, David, Xu, Ning, Li, Mingjie, Green, Tracy, Fung, Eddie, Aquino, Elias, Swift, Regina, Eshaghian, Shahrooz, Feinstein, Aaron, Berenson, James R.
Publicado 2021

Acute and Post-Acute COVID-19 Severity and Mortality in Patients with Hematologic Malignancies: A Population-Based Registry Study

por Martinez-Lopez, Joaquin, De La Cruz, Javier, Gil-Manso, Rodrigo, Cedillo, Angel, Alegre, Adrian, Llamas Sillero, Maria Pilar, Duarte, Rafael F., Jiménez-Yuste, Víctor, Hernandez, jose Angel, Kwon, Mi, Sanchez Godoy, Pedro, Martinez-Barranco, Pilar, Colás Lahuerta, Blanca, Herrera Puente, Pilar, Benito, Lauren, Velasco, Alberto, Matilla, Arturo, Alaez, Concha, Martos, Rafael, Martínez-Chamorro, Carmen, Quiroz, Keina, del Campo, Juan F, De La Fuente, Adolfo, Herraez, Maria Regina, Pascual, Adriana, Gomez, Elvira, Perez De Oteyza, Jaime, Ruiz, Elena, Diez Martin, Jose Luis, Garcia-Suarez, Julio
Publicado 2021

BNT162b2 mRNA COVID-19 Vaccination (BNTCV) in Patients (Pts) Having Hematological Malignancies (HM): Early tolerance with telemedicine application connecting and antibody anti-Spik...

por Rossi, Jean-Francois, Bonnet, Emmanuel, Velensek, Marion, Wisniewski, Emma, Heraud, Sophie, Boustany, Rania, David, Celeste, Dinet, Jerome, Sicard, Roland, Daures, Jean Pierre, Bonifacy, Marion, Mousset, Lysiane, Goffard, Emmanuel
Publicado 2021

Sickle Cell Disease and COVID-19 Infection: A Single-Center Experience

por Devarashetty, Sindhu, Le Blanc, Kimberly, Grewal, Udhayvir Singh, Walton, Jacqueline, Jones, Tabitha, Shi, Runhua, Master, Samip R, Mansour, Richard Preston, Ramadas, Poornima
Publicado 2021

Antibody Response after One and/or Two Doses of BNT162b2 Anti- Sars-Cov-2 mRNA Vaccine in Patients Treated By CAR T-Cells Therapy

por Gastinne, Thomas, Le Bourgeois, Amandine, Coste-Burel, Marianne, Guillaume, Thierry, Peterlin, Pierre, Garnier, Alice, Imbert, Berthe-Marie, Drumel, Thomas, Mahé, Béatrice, Dubruille, Viviane, Blin, Nicolas, Lok, Anne, Touzeau, Cyrille, Tessoulin, Benoit, Jullien, Maxime, Vantyghem, Sophie, Bene, Marie C, Moreau, Philippe, Le Gouill, Steven, Chevallier, Patrice
Publicado 2021

Characteristics and Outcomes of COVID-19 Patients with Mature B-Cell Non-Hodgkin Lymphomas (mB-Cell NHL): A US Nationwide Electronic Health Record (EHR) Database Study

por Yue, Xiaomeng, Hallett, David, Liu, Yangyang, Iyengar, Reethi, Basa, Elisa, Yang, Huiying
Publicado 2021

COVID-19 Vaccine Response in Patients with Hematologic Malignancy: A Systematic Review and Meta-Analysis

por Gong, Inna, Vijenthira, Abi, Betschel, Stephen, Hicks, Lisa K., Cheung, Matthew
Publicado 2021

Safety and immunogenicity of the SARS-CoV-2 ARCoV mRNA vaccine in Chinese adults: a randomised, double-blind, placebo-controlled, phase 1 trial

por Chen, Gui-Ling, Li, Xiao-Feng, Dai, Xia-Hong, Li, Nan, Cheng, Meng-Li, Huang, Zhen, Shen, Jian, Ge, Yu-Hua, Shen, Zhen-Wei, Deng, Yong-Qiang, Yang, Shu-Yuan, Zhao, Hui, Zhang, Na-Na, Zhang, Yi-Fei, Wei, Ling, Wu, Kai-Qi, Zhu, Meng-Fei, Peng, Cong-Gao, Jiang, Qi, Cao, Shou-Chun, Li, Yu-Hua, Zhao, Dan-Hua, Wu, Xiao-Hong, Ni, Ling, Shen, Hua-Hao, Dong, Chen, Ying, Bo, Sheng, Guo-Ping, Qin, Cheng-Feng, Gao, Hai-Nv, Li, Lan-Juan
Publicado 2022